Search Results - Marcus Lind
- Showing 1 - 20 results of 21
- Go to Next Page
-
1
Evaluating a systematic intensive therapy using continuous glucose monitoring and intermittent scanning glucose monitoring in clinical diabetes care: a protocol for a multi-center... by Arndís F. Ólafsdóttir, Arndís F. Ólafsdóttir, Arndís F. Ólafsdóttir, Marcus Lind, Marcus Lind, Marcus Lind
Published in Frontiers in Clinical Diabetes and Healthcare (2023-10-01)Get full text
Article -
2
Inhibition of leukotrienes and their potential role in type 1 diabetes pathogenesis: implications for montelukast as a therapeutic agent: a case report by Pavel Fatulla, Pavel Fatulla, Ingela Ström, Christine Lingblom, Christine Lingblom, Marcus Lind, Marcus Lind, Marcus Lind
Published in Frontiers in Clinical Diabetes and Healthcare (2024-12-01)Get full text
Article -
3
Design and methods of a multicenter randomized clinical trial of effects of diabetes-educated psychologist on glucose management and diabetes distress by Johanna Zeijlemaker, Therese Anderbro, Sofia Sterner Isaksson, Sofia Sterner Isaksson, Marcus Lind, Marcus Lind, Marcus Lind
Published in Frontiers in Clinical Diabetes and Healthcare (2025-04-01)Get full text
Article -
4
Design of a randomized cross-over study evaluating effects of carbohydrate intake on glycemic control in persons with type 1 diabetes by Sofia Sterner Isaksson, Sofia Sterner Isaksson, Arndís F. Ólafsdóttir, Arndís F. Ólafsdóttir, Marcus Lind, Marcus Lind, Marcus Lind
Published in Frontiers in Nutrition (2023-03-01)Get full text
Article -
5
-
6
Prevalence and risk factors for diabetic retinopathy at diagnosis of type 2 diabetes: an observational study of 77 681 patients from the Swedish National Diabetes Registry by Marcus Lind, Katarina Eeg-Olofsson, Sheyda Sofizadeh
Published in BMJ Open Diabetes Research & Care (2024-06-01)Get full text
Article -
7
-
8
Incidence and risk factors for mortality and end-stage renal disease in people with type 2 diabetes and diabetic kidney disease: a population-based cohort study in the UK by Marcus Lind, Antonio González-Pérez, David Vizcaya, Maria Saez, Luis Garcia Rodriguez
Published in BMJ Open Diabetes Research & Care (2021-03-01)Get full text
Article -
9
Trends in Survival After First Myocardial Infarction in People With Diabetes by Linn Glynn, Marcus Lind, Tomas Andersson, Björn Eliasson, Robin Hofmann, Thomas Nyström
Published in Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease (2024-05-01)Get full text
Article -
10
Estimated glucose disposal rate is associated with retinopathy and kidney disease in young people with type 1 diabetes: a nationwide observational study by Wedén Linn, Martina Persson, Björn Rathsman, Johnny Ludvigsson, Marcus Lind, Mikael Andersson Franko, Thomas Nyström
Published in Cardiovascular Diabetology (2023-03-01)Get full text
Article -
11
Excess risk of lower extremity amputations in people with type 1 diabetes compared with the general population: amputations and type 1 diabetes by Annika Rosengren, Marcus Lind, Soffia Gudbjörnsdottir, Ann-Marie Svensson, Arndís Finna Ólafsdóttir, Thomas Nyström, Hans Wedel
Published in BMJ Open Diabetes Research & Care (2019-05-01)Get full text
Article -
12
Phase III, randomised, double-blind, placebo-controlled, multicentre trial to evaluate the efficacy and safety of rhGAD65 to preserve endogenous beta cell function in adolescents a... by Marcus Lind, Johnny Ludvigsson, Christoph Nowak, Linnea Eriksson, Pedro F Teixeira, Martina Widman, Anton Lindqvist, Rosaura Casas, Ulf Hannelius
Published in BMJ Open (2022-10-01)Get full text
Article -
13
Trajectories in HbA1c and other risk factors among adults with type 1 diabetes by age at onset by Lena Björck, Annika Rosengren, Marcus Lind, Stefan Franzén, Ann-Marie Svensson, Araz Rawshani, Jon Edqvist, Aidin Rawshani, Martin Adiels
Published in BMJ Open Diabetes Research & Care (2021-03-01)Get full text
Article -
14
The association between HbA1c, fasting glucose, 1-hour glucose and 2-hour glucose during an oral glucose tolerance test and cardiovascular disease in individuals with elevated risk... by Marcus Lind, Jaakko Tuomilehto, Matti Uusitupa, Olle Nerman, Johan Eriksson, Pirjo Ilanne-Parikka, Sirkka Keinänen-Kiukaanniemi, Markku Peltonen, Aldina Pivodic, Jaana Lindström
Published in PLoS ONE (2014-01-01)Get full text
Article -
15
Effects of nutrition education using a food-based approach, carbohydrate counting or routine care in type 1 diabetes: 12 months prospective randomized trial by Marcus Lind, Björn Eliasson, Araz Rawshani, Ulf Lindblad, Johan Jendle, Sofia Sterner Isaksson, Margareta Bensow Bacos, Eva Thors Adolfsson, Agneta Berglund, Mette Axelsen
Published in BMJ Open Diabetes Research & Care (2021-05-01)Get full text
Article -
16
Systematic intensive therapy in addition to continuous glucose monitoring in adults with type 1 diabetes: a multicentre, open-label, randomised controlled trialResearch in context by Arndís F. Ólafsdóttir, Kari-Anne Sveen, Magnus Wijkman, Sara Hallström, Per-Henrik Nilsson, Sofia Sterner Isaksson, Helene Holmer, Marie Ekström, Henrik Imberg, Marcus Lind
Published in The Lancet Regional Health. Europe (2025-12-01)Get full text
Article -
17
Diabetes status and other factors as correlates of risk for thrombotic and thromboembolic events during SARS-CoV-2 infection: A nationwide retrospective case–control study using Ce... by Marcus Lind, Mark A Clements, Diana Ferro, Osagie Ebekozien, Erin M Tallon, Mary Pat Gallagher, Vincent S Staggs, Deepa Badrinath Murthy, Mikhail N Kosiborod, Camila Manrique-Acevedo, Chi-Ren Shyu
Published in BMJ Open (2023-07-01)Get full text
Article -
18
An “All-Data-on-Hand” Deep Learning Model to Predict Hospitalization for Diabetic Ketoacidosis in Youth With Type 1 Diabetes: Development and Validation Study by David D Williams, Diana Ferro, Colin Mullaney, Lydia Skrabonja, Mitchell S Barnes, Susana R Patton, Brent Lockee, Erin M Tallon, Craig A Vandervelden, Cintya Schweisberger, Sanjeev Mehta, Ryan McDonough, Marcus Lind, Leonard D'Avolio, Mark A Clements
Published in JMIR Diabetes (2023-07-01)Get full text
Article -
19
Toward a Clinically Actionable, Electronic Health Record–Based Machine Learning Model to Forecast 90-Day Change in Hemoglobin A1c in Youth With Type 1 Diabetes: Feasibility and Mod... by Erin M Tallon, David D Williams, Cintya Schweisberger, Colin Mullaney, Brent Lockee, Diana Ferro, Craig A Vandervelden, Mitchell S Barnes, Angelica Cristello Sarteau, Anna R Kahkoska, Susana R Patton, Sanjeev Mehta, Ryan McDonough, Marcus Lind, Leonard D'Avolio, Mark A Clements
Published in JMIR Diabetes (2025-09-01)Get full text
Article -
20
Real-world cardiovascular effectiveness of sustained glucagon-like peptide 1 GLP-1 receptor agonist usage in type 2 diabetes by Kathrine Kold Sørensen, Puriya Daniel Würtz Yazdanfard, Bochra Zareini, Ulrik Pedersen-Bjergaard, Vanja Kosjerina, Mikkel Porsborg Andersen, Anders Munch, Johan Sebastian Ohlendorff, Stefanie Schmid, Stefanie Lanzinger, Pratik Choudhary, Clare Gillies, Safoora Gharibzadeh, Marcus Lind, Viktor Tasselius, Jens Michelsen, Thomas Alexander Gerds, Christian Torp-Pedersen
Published in Cardiovascular Diabetology (2025-10-01)Get full text
Article
